To ascertain the existence of the kallikrein-kinin system in the heart, we have studied in vivo and in vitro whether rat cardiac tissue expresses kininogen, kallikrein and kinin receptor mRNAs. The reverse transcription-polymerase chain reaction demonstrated that the ventricular myocardium of adult male rats expressed mRNAs for T-and low-molecularweight (L-) kininogens, tissue kallikreins such as true kallikrein and T-kininogenase, and bradykinin B2 receptor, but not those for high-molecular-weight kininogen and B1 receptor. Lipopolysaccharide (LPS; 0.5 mg/kg, i.v.) increased the levels of mRNA for T-kininogen at 12 h and the bradykinin B1 receptor at 24 h without affecting that for other components. All of these mRNAs for the kallikrein-kinin system were also detected in cultured cardiomyocytes derived from neonatal rat ventricles; dibutyryl cyclic AMP, LPS or inflammatory cytokines such as interleukin-1 and tumor necrosis factor, upregulated mRNA expression of T-kininogen, T-kininogenase, or B1 receptor in these cells in vitro. These results suggest that there are two kinin-generating systems in rat myocardium comprising T-kininogen/T-kininogenase and L-kininogen/true kallikrein respectively, and that the former may be relatively important in inflammatory diseases or conditions in which cAMP levels increase in cardiomyocytes. ß
Introduction
Numerous studies have demonstrated that angiotensin-converting enzyme (ACE) inhibitors can improve survival in patients or animals with severe heart failure, delay the development of heart failure in patients or animals with a symptomatic left ventricular dysfunction, and reduce short-and long-term mortality in patients or animals surviving myocardial infarction [1^3] . These bene¢cial e¡ects of ACE inhibitors have been attributed to not only a decrease in the local cardiac formation of angiotensin II, but also a potentiation of kinin activity [4] and/or inhibition of its degradation [5^11] .
Bradykinin or its analogues are released from kininogens by the proteolytic action of kallikreins, exert their activities through binding to B1 or B2 receptors, and show a broad spectrum of biological e¡ects including vasodilation, blood pressure reduction, smooth muscle relaxation and contraction, pain induction, and in£ammation [12, 13] . Since concentrations of kinins in blood are very low, the formation of kinin by the kallikrein-kinin system has been considered to operate mainly at the local tissue level [14] . Consequently, a reliable method for the measurement of kinin levels in tissue has demonstrated levels much higher than in the circulation in rats, suggesting the formation at local sites [15] .
The role of kinins as possible mediators for the endogenous cardioprotective mechanisms as well as the therapeutic bene¢ts of ACE inhibitors in heart failure is based on the existence of local kallikreinkinin system in cardiac tissues. Nolly et al. found that slices of rat heart secreted a kininogen-like protein from which an immunoreactive kinin was released by trypsin digestion [16] . They also demonstrated that tissue kallikrein mRNA was present in both atrial and ventricular tissues of rat heart by reverse transcription-polymerase chain reaction (RT-PCR). Chao et al. reported that rat heart contained a kininogen-like protein whose levels elevated on the induction of acute in£ammation [17] . In addition, heart tissues and cardiomyocytes express functional B2 receptors, suggesting that cardiomyocytes are not only a source of kinins, but also a target for kinin-mediated e¡ects [18^21] .
The present study has been carried out to characterize mRNA expressions of kininogens, kallikreins and bradykinin receptors in rat heart in vivo and in isolated cardiomyocytes in vitro. The results indicate that rat cardiomyocytes as well as cardiac tissues express mRNAs for these components and that various factors, such as lipopolysaccharide (LPS), cyclic AMP and cytokines, in£uence their levels.
Materials and methods

Materials
The following chemicals were obtained from commercial sources: LPS (Staphylococcus typhosa 0901) from Difco (Detroit, MI); angiotensin II (AII) and bradykinin from Peptide Institute (Osaka); dibutyryl cyclic AMP (Bt 2 cAMP) from Boehringer-MannheimYamanouchi (Tokyo); phorbol 12-myristate 13-acetate (PMA) from Nacalai tesque (Kyoto); recombinant mouse interleukin-6 (IL-6; 1U10 8 U/mg) from Genzyme. Recombinant human interleukin-1K (IL-1; 2U10 7 U/mg) and tumor necrosis factor K (TNF; 3U10 6 U/mg) were donated by Dainippon Pharmaceutical (Osaka).
Animals and LPS treatment
Sprague-Dawley male rats, weighing 140^160 g, were injected intravenously with LPS at a dose of 0.5 mg/kg, then sacri¢ced at 12, 24, and 48 h. Ventricles of the heart were isolated.
Culture of neonatal rat cardiomyocytes
Two-to 4-day-old Sprague-Dawley rats were used for the isolation of cardiac myocytes and nonmyocytes. The ventricular cardiac cells were dispersed in Hanks' balanced salt solution containing 0.04% collagenase II and 0.06% pancreatin (Gibco) as previously reported [22] . Cardiac myocytes and nonmyocytes were separately collected by the discontinuous Percoll gradient method [22] . Brie£y, a discontinuous gradient of Percoll consisting of 40.5% and 58.5% was prepared in the Hanks' balanced salt solution, and cardiac cells were suspended in a layer of 58.5% Percoll. After centrifugation at 850Ug for 30 min at 15³C, myocytes migrated to the interface of discontinuous layers, and nonmyocytes to the surface of the layer of 40.5% Percoll. Puri¢ed cardiomyocytes or nonmyocytes were plated at a density of 3U10 4 cells/cm 2 in Dulbecco's modi¢ed Eagle's medium (DME) containing 10% fetal bovine serum (FBS). After culture for 24 h, the medium was replaced with fresh DME containing 10% FBS with or without various agents. After a further 24 h culture, cells were harvested to extract total RNA. Using this method, we routinely obtained contractile myocyterich cultures with 90^95% myocytes as assessed using immunocytochemistry with a monoclonal antibody against L-myosin heavy chain.
Detection of kininogen and tissue kallikrein mRNAs in myocardium and cardiomyocytes
Total RNA was extracted with acid guanidiniumphenol-chloroform from isolated myocardium or cultured cardiomyocytes [23] . We used RT-PCR followed by Southern blotting for detecting mRNAs of kininogens and tissue kallikreins, such as highmolecular-weight (H-), low-molecular-weight (L-) and T-kininogens, true kallikrein (rKLK1), and T-kininogenase (rKLK10), as described previously [24] . . The forward and reverse primers for B1 receptor were 5P-AGAAACCTCCCAAGACAGCA-3P (nucleotides 26^45) and 5P-AGGAATGTGGGGA-TGCTCAA-3P (nucleotides 679^698), respectively. The forward and reverse primers for B2 receptor were 5P-GGACCATGAAGGACTACAGG-3P (nucleotides 891^910) and 5P-TAGGCCACGTAGGA-ACTGAT-3P (nucleotides 1250^1269), respectively. A speci¢c oligonucleotide for B1 receptor (5P-AGTA-CAGGAGGTCAAAT-3P) was used as an internal probe for hybridization. The probe for Southern hybridization of B2 receptor was a 400 bp fragment of B2 receptor cDNA.
Results
Detection of kininogen mRNAs in rat ventricular myocardium
Three types of kininogens have been found so far in mammalian species; these di¡er by molecular weight and susceptibility to various kininogenases [25] . Two of them, H-and L-kininogen, are present throughout the mammalian lineage, whereas the third type, T-kininogen, is considered to be unique for the rat [25] . We attempted to detect H-, L-, and T-kininogen mRNAs in rat myocardium by RT-PCR and found a faint signal corresponding to T-and L-kininogen cDNAs ( Fig. 1) , while no signal corresponding to H-kininogen mRNA (data not shown). Since we used a set of primers common for T-and L-kininogen mRNAs, the RT-PCR products seemed to be a mixture of cDNAs ampli¢ed from both Tand L-kininogen mRNAs. Induction of systemic in£ammation following i.v. injection of LPS resulted in increased levels of T/L-kininogen mRNA in rat ventricle within 12 h (Fig. 1) , while there was no induction of the H-kininogen mRNA during 48 h after the LPS treatment (data not shown). To determine Fig. 1 . Southern blot analysis of cDNA products generated from rat ventricular myocardium by RT-PCR using primers and probe common for both T-and L-kininogen. Rats were injected with LPS (0.5 mg/kg, i.v.), then four rats each were sacri¢ced at 12, 24 and 48 h by bleeding under ether anesthesia. Four untreated animals were sacri¢ced as an untreated control. Ventricular myocardium was isolated and total RNA was extracted. One Wg RNA samples were analyzed by RT-PCR (40 cycles) followed by Southern blotting using T-kininogen cDNA as a probe, and two blots from two animals for each time point after LPS injection are shown as representative of the results. Bands in the upper panel represent a mixture of T-and L-kininogen cDNAs. The bottom panel shows Southern blots of the RT-PCR products ampli¢ed (25 cycles) for glyceraldehyde dehydrogenase (GAPDH) cDNA.
whether RT-PCR products corresponding in size to T-and L-kininogen cDNAs were actually composed of these cDNAs, RT-PCR was carried out using a £uorescent Cy5-labeled forward primer common for both T-and L-kininogen cDNAs, then labeled cDNA products were resolved by an ALFred DNA sequencer (Pharmacia) on the basis of a 6 bp di¡er-ence in cDNA products between T-(315 bp) and L-(321 bp) kininogens as described previously [24] . The RT-PCR products of untreated rat hearts revealed two faint peaks corresponding to T-and L-kininogen cDNAs (Fig. 2) . cDNA products of LPS-treated rat hearts comprised a clear large peak of T-kininogen cDNA and a faint peak of L-kininogen cDNA (Fig.  2) . Thus it was concluded that the rat myocardium expressed both T-and L-kininogen mRNAs and that LPS exclusively stimulated an expression of the T-kininogen gene.
Detection of kininogen mRNAs in rat cardiomyocytes in vitro
We recently reported that T-kininogen mRNA was present in rat ¢broblasts [26] and vascular smooth muscle cells [24] , and found that the expression by ¢broblasts was stimulated by Bt 2 cAMP and cytokines such as TNF, IL-1 and IL-6, while that by vascular smooth muscle cells was enhanced by LPS, PMA and angiotensin II. Thus it may be that these cells rather than cardiomyocytes are the source of kininogen mRNA in myocardium. To determine which type of cell in rat myocardium expresses kininogen mRNA, cardiac cells from neonatal rat heart were separated into myocytes and nonmyocytes, then cultured in vitro. As shown in the representative autoradiogram in Fig. 3 , although no signal corresponding to T/L-kininogen mRNA was detected in cultured myocytes, a distinct signal for T/L-kininogen mRNA was observed in myocytes after 24 h culture with LPS (0.5 Wg/ml) or Bt 2 cAMP (1 mM), while not with PMA (10 WM) and cytokines, such as TNF (500 U/ML), IL-1 (500 U/ml) and IL-6 (500 U/ ml). In contrast, a faint signal corresponding to T/L- Fig. 2 . Separation of RT-PCR products of T-and L-kininogen mRNAs in rat ventricular myocardium by polyacrylamide gel electrophoresis. Total RNA samples were prepared from myocardium of untreated or LPS-pretreated rats (24 h, 0.5 mg/kg, i.v.). The cDNAs transcribed from these samples were ampli¢ed by 18 cycles using a £uorescence-labeled 5P-primer and non-labeled 3P-primer which were speci¢c for both T-and L-kininogen cDNAs. The labeled products were separated by polyacrylamide gel electrophoresis and analyzed using an ALFred DNA sequencer (Pharmacia; lower panel). The retention times for authentic T-kininogen and L-kininogen cDNAs were 264 and 269 min, respectively (upper panel). Experiments were carried out with RNA samples from four untreated and four LPS-treated animals, and representative results are shown. Fig. 3 . Detection of kininogen mRNAs in rat cardiomyocytes by RT-PCR followed by Southern blotting. Rat cardiomyocytes were cultured with or without Bt 2 cAMP (1 mM), LPS (0.5 Wg/ ml), PMA (10 WM), TNF (500 U/ml), IL-1 (500 U/ml) or IL-6 (500 U/ml) for 24 h. Total RNA was extracted and subjected to RT-PCR for T/L-kininogen mRNA (40 cycles) or H-kininogen mRNA (40 cycles), then Southern blotting of the cDNA products was carried out using T-kininogen or H-kininogen cDNA as a probe, respectively. Experiments were carried out 4 times for each treatment, and representative results are shown.
kininogen mRNA was also detected in nonmyocytes, but the levels were not in£uenced by treatment with LPS, Bt 2 cAMP, PMA and cytokines (data not shown). Polyacrylamide gel electrophoresis of cDNA products demonstrated that rat cardiomyocytes expressed both T-and L-kininogen mRNAs, and that levels of T-kininogen mRNA but not of L-kininogen mRNA were increased by culture with LPS or Bt 2 cAMP (data not shown). No detectable signal for H-kininogen mRNA was found in either cardiomyocytes or nonmyocytes (data not shown). Western blotting using a rabbit anti-T-kininogen antibody demonstrated that a T-kininogen-like protein with a molecular mass of 68 kDa was present in the conditioned medium of cardiomyocytes that had been cultured for 24 h with 1 mM Bt 2 cAMP, but not in medium of untreated cardiomyocytes, suggesting that rat cardiomyocytes secrete T-kininogen in response to Bt 2 cAMP (data not shown). These results indicate that rat cardiomyocytes are a source of Tand L-kininogens, and that the expression of the Tkininogen but not the L-kininogen gene is stimulated by LPS and Bt 2 cAMP.
Detection of tissue kallikrein mRNAs in rat ventricular myocardium and cardiomyocytes
Rats have more than ten members of the tissue kallikrein family. Of these members, true kallikrein encoded by rKLK1 has a kinin-liberating activity for L-and H-kininogens [13] , but not T-kininogen [27] , and T-kininogenase encoded by rKLK10 has a kininogenase activity for T-kininogen [28] . Consistent with a report by Nolly et al. [16] , we con¢rmed the presence of mRNA for true kallikreinin in rat myocardium, and that the levels did not change after an i.v. injection of LPS (Fig. 4) . Since T-kininogen appeared to be a major kininogen produced by rat cardiac tissues, we tried to detect mRNA for rKLK10. As shown in Fig. 4 , T-kininogenase mRNA was also detected in RNA samples from rat myocardium, and the levels were not altered by LPS injection. Tissue kallikrein mRNAs for rKLK1 and rKLK10 were detected in cultured cardiomyocytes (Fig. 5 ), but not in nonmyocytes (data not shown). Neither LPS (5 Wg/ml), PMA (10 nM) nor cytokines (500 U/ml) in£uenced the levels of these kallikrein mRNAs in cardiomyocytes, but Bt 2 cAMP 5 . Detection of tissue kallikrein mRNAs in rat cardiomyocytes by RT-PCR followed by Southern blotting. Rat cardiomyocytes were cultured with or without Bt 2 cAMP (1 mM), LPS (0.5 Wg/ml), PMA (10 WM), TNF (500 U/ml), IL-1 (500 U/ ml) or IL-6 (500 U/ml) for 24 h, then RNA samples were ampli¢ed by RT-PCR for true kallikrein (35 cycles), T-kininogenase (40 cycles) and GAPDH (25 cycles) and Southern blotted. Experiments were carried out 4 times for each treatment, and representative results are shown.
(1 mM) caused an increase in levels of T-kininogenase mRNA (Fig. 5) .
Detection of B1 and B2 receptor mRNAs in rat ventricular myocardium and cardiomyocytes
By RT-PCR Southern hybridization, we detected bradykinin B2 receptor mRNA in either rat myocardium or cultured cardiomyocytes, and the levels were not a¡ected by the injection of or culture with LPS (Figs. 6 and 7) . Although B1 receptor mRNA could not be detected in untreated rat hearts, LPS injection caused a marked induction of B1 receptor mRNA at 12^24 h (Fig. 6 ). B1 receptor mRNA was detectable in cultured cardiomyocytes, and the level was increased after culture with LPS (5 Wg/ml), IL-1 (500 U/ml) and TNF (500 U/ml), but decreased by IL-6 (500 U/ml) (Fig. 7) . These agents did not a¡ect the levels of B2 receptor mRNA in cardiomyocytes.
Discussion
The present study provides the ¢rst evidence that rat cardiomyocytes are the source of T-kininogen, a unique kininogen in the rat, but poor sources of Hand L-kininogens. T-kininogen has been characterized as a protein highly homologous in structure to rat L-kininogen as well as one of the acute-phase proteins in the rat [27, 29] . This protein is produced not only by hepatocytes but also by ¢broblasts and vascular smooth muscle cells [24, 26] . In fact, T-kininogen mRNA has been detected in several tissues of rats, such as the liver, lung, kidney and heart [17, 30] . However, Barka and van der Noen have reported that the T-kininogen gene is not expressed in rat heart on the basis of ¢ndings that T-kininogen mRNA was not detectable by a sensitive RT-PCR method in cardiac tissue of either normal or turpentine-injected rats [31] . In contrast to their results, we detected T-kininogen mRNA in rat ventricular myocardium and found that the level was increased after injection of LPS. Furthermore, cardiomyocytes from neonatal rat hearts not only contained T-kininogen mRNA but also secreted immunoreactive T- Fig. 7 . Detection of bradykinin B1 and B2 receptor mRNAs in rat cardiomyocytes by RT-PCR followed by Southern blotting. Rat cardiomyocytes were cultured with or without Bt 2 cAMP (1 mM), LPS (0.5 Wg/ml), PMA (10 WM), TNF (500 U/ml), IL-1 (500 U/ml) or IL-6 (500 U/ml) for 24 h, then RNA samples were ampli¢ed by RT-PCR for B1 receptor (40 cycles), B2 receptor (35 cycles) and GAPDH (25 cycles) followed by Southern blotting. Experiments were carried out 4 times for each treatment, and representative results are shown. Fig. 6 . Detection of bradykinin B1 and B2 receptor mRNAs in rat ventricular myocardium by RT-PCR followed by Southern blotting. RNA samples were obtained from the ventricular myocardium of untreated and LPS-pretreated rats, as described in the legend of Fig. 1 . One Wg of the sample was analyzed by RT-PCR followed by Southern blotting for B1 receptor (40 cycles), B2 receptor (35 cycles) and GAPDH (25 cycles). The ¢gure shows two blots from two animals for each time point after LPS injection as representative of the results. kininogen in culture. Since we used the same primers for detecting T-kininogen mRNA as they used, the reason for this discrepancy is not obvious. Interestingly, an addition of LPS to cultures resulted in increased levels of T-kininogen mRNA in cardiomyocytes, suggesting that LPS acts directly on cardiomyocytes to induce the T-kininogen gene rather than indirectly by LPS-induced mediators, such as IL-1 and IL-6. This may be why the T-kininogen mRNA level was not elevated in rat heart even after induction of in£ammation by turpentine [31] . The fact that little T-kininogen mRNA was detected in nonmyocytes in the presence or absence of LPS in vitro suggests that cardiomyocytes are the major cells expressing the T-kininogen gene in rat heart.
When RT-PCR products ampli¢ed by primers common for T-and L-kininogen mRNAs were resolved on polyacrylamide gel electrophoresis, we observed a faint peak with a retention time corresponding to L-kininogen cDNA in RNA samples, suggesting the presence of L-kininogen mRNA in cardiomyocytes. However, the levels were very low in comparison to the T-kininogen mRNA level and did not change after LPS treatment in vivo or in vitro, making the physiological relevance unclear. In addition, we could not detect H-kininogen mRNA in either ventricular myocardium or cardiomyocytes, even by a sensitive RT-PCR method. Thus it is likely that rat cardiomyocytes are poor sources of L-and/or H-kininogens. Nolly et al. reported that rat cardiac slices secreted a kininogen which liberated bradykinin-like immunoreactivity by trypsin digestion [16] , providing the ¢rst evidence for the presence of cardiac kininogen. It is well known that T-kininogen releases Ile-Ser-bradykinin by trypsin digestion and that this bradykinin analogue is recognized by polyclonal anti-bradykinin antibodies. Thus, our ¢ndings, together with the evidence described above, indicate that the cardiac kininogen in the rat is mainly T-kininogen, not H-and L-kininogens.
As demonstrated by Nolly et al., rat cardiac tissues and cardiomyocytes synthesize and secrete a tissue kallikrein corresponding to the true kallikrein [16] . In addition to this subtype of tissue kallikreins, we found the mRNA of T-kininogenase to be present in rat cardiomyocytes. Ma et al. have demonstrated that T-kininogenase is expressed in the rat at high levels in the submandibular gland and low levels in the kidney, but not at all in seven other tissues, including the heart [28] . In contrast, our present study showed that mRNA for T-kininogenase was detectable in rat cardiomyocytes as well as ventricular myocardium. Since we used the same primers for detecting T-kininogenase as reported by Ma et al., the discrepancy in the ¢ndings is probably due to the di¡erences in conditions for RT-PCR, including temperature, reaction times and PCR cycles. Of interest, the levels of T-kininogenase mRNA in cardiomyocytes elevated after the culture with Bt 2 cAMP. Thus the treatment of cardiomyocytes with Bt 2 cAMP induced the gene expression of not only T-kininogen but also T-kininogenase, suggesting that the elevation of intracellular cAMP levels in cardiomyocytes results in the increased production of both T-kininogen and T-kininogenase. In fact, we observed increased levels of T-kininogen mRNA in cardiomyocytes after culture with 10 38 M isoproterenol (data not shown). Since T-kininogenase liberates Ile-Ser-bradykinin from T-kininogen, one may speculate that the cardiac kallikrein-kinin system in the rat comprises T-kininogen and T-kininogenase rather than H/L-kininogen and true tissue kallikrein.
There are at least two subtypes of bradykinin receptors, B1 and B2, in mammalian tissues; the majority of the classical actions of bradykinin have been attributed to an activation of B2 receptor, whereas B1 receptors, unique as an inducible receptor activated by in£ammatory stimuli, appear to be involved in chronic in£ammatory responses [32^34]. The existence of these two subtypes of bradykinin receptors in cardiac tissues has been con¢rmed by means of radioligand binding [18] . Consistent with ¢ndings by other investigators [35^37], we detected B2 receptor mRNA in ventricular myocardium of either untreated or LPS-injected rats, while detecting B1 receptor mRNA only after injection of LPS. Similar results were obtained in the in vitro experiments using rat cardiomyocytes in which mRNA levels for B1 receptor but not for B2 receptor were elevated after cultures with LPS. Ni et al. reported that the 5P-£anking region of the human B1 receptor showed promoter activity inducible by LPS and proin£am-matory cytokines, such as IL-1 or TNF, in vascular smooth muscle cells [38] . As shown in the present study, the exposure of rat cardiomyocytes to LPS, IL-1 and TNF in vitro also produced an elevation in the B1 receptor mRNA level, suggesting that the inducible process for B1 receptor seen in vascular smooth muscle cells exists in cardiomyocytes. It should be noted that B1 receptor mRNA was detectable in untreated cells, suggesting the induction of B1 receptor following the isolation and in vitro incubation of cardiomyocytes [39^42] . In contrast to IL-1 and TNF, another proin£ammatory cytokine, IL-6, suppressed B1 receptor mRNA levels in cultured cardiomyocytes, suggesting a potential regulatory role for IL-6 in the upregulation of B1 receptors following tissue injury or in£ammation. Further studies will be needed to clarify the importance of IL-6 to the pathophysiological role of the B1 receptor.
In conclusion, the present study has demonstrated that cardiomyocytes in rat ventricular myocardium express mRNAs for the kallikrein-kinin system, such as kininogens, kallikreins and B1/B2 receptors. However, this system in myocardium seems to be unique to the rat in that the only kininogen synthesized locally in myocardium appears to be T-kininogen, a unique kininogen in the rat. Ile-Ser-bradykinin may possibly be generated in rat heart and serve as the cardioprotective kinin. Since this kinin-generating system is not present in humans and other animals, further studies are needed to clarify the existence of the independent kallikrein-kinin system in cardiomyocytes of these species.
